Indinavir: Difference between revisions
From Proteopedia
Jump to navigationJump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
<applet load="" size="480" color="" frame="true" spin="on" Scene ="" align="right" caption=""/> | <applet load="" size="480" color="" frame="true" spin="on" Scene ="" align="right" caption=""/> | ||
===Better Known as:=== | ===Better Known as: Crixivan=== | ||
* Marketed By:<br /> | * Marketed By: Merck & Co.<br /> | ||
* Major Indication: [[Human Immunodeficiency Virus]] Infection<br /> | * Major Indication: [[Human Immunodeficiency Virus]] Infection<br /> | ||
* Drug Class: [[HIV Protease]] Inhibitor | * Drug Class: [[HIV Protease]] Inhibitor | ||
* Date of FDA Approval (Patent Expiration): <br /> | * Date of FDA Approval (Patent Expiration): 1996 (2014) <br /> | ||
* 2006 Sales: | * 2006 Sales: | ||
* Importance: | * Importance: | ||
